written on 29.05.2014
Tags:
,

With new hopes for German pricing, Novo Nordisk decides to roll out Tresiba there

TAGS: ,

Novo Nordisk has decided to play ball in Germany. The Danish drugmaker now plans to launch its brand-new diabetes drug Tresiba in that country, despite a notorious pricing policy that Novo feared would interfere with its success.

Latest Report